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ABSTRACT 
Objective: Carvedilol is antihypertensive. It is practically water insoluble. Therefore, the objective of this investigation is a formulation and 
characterization of carvedilol nano emulsion (NE) employing orally to increase carvedilol solubility for enhancing of carvedilol bioavailability. 
Methods: The formulation components were chosen according to the solubility study. The diagrams of pseudo-ternary phase were made using the 
aqueous phase titration method. The formulated nanoemulsions were subjected to various thermodynamic stability assays. We selected eight of 
formulas that have thermodynamic stability for further optimization for various characterizations in order to select the best formula. 
Results: The carvedilol NE3 considered a selected formula. It composes of 1.25 mg carvedilol per g of the nanoemulsion, 10 % of peppermint oil, 20% of 
tween80, 10% ethanol and 60% of distilled water. It was characterized by a low globule size range, low poly dispersity index, higher zeta potential, good pH 
value, efficient electroconductivity, classy percent of light transmittance, higher % drug content, acceptable low viscosity and carvedilol release was 
significantly higher (P<0.05) in dissolution rate. The carvedilol NE3 subject for further investigations. Fourier transformed infrared spectroscopy confirm no 
incompatibility between the drug and excipients. The atomic force microscopy study shows that system in nanoscale and has high stability. 
Conclusion: The selected formula (carvedilol NE3) was a promising nanoemulsion formula that increases the carvedilol solubility result in an 
increment of its bioavailability. 
Keywords: Nanoemulsion, Carvedilol, Solubility studies, Peudoternary phase diagrams. 
 
INTRODUCTION 
The therapeutic level relies upon plasma drug concentration to 
attain pharmacological response. Solubility is one of the very 
important factors to achieve an aspired concentration of the drug in 
the blood circulation to remain above minimum effective 
concentration and within therapeutic range to reach 
pharmacological recriminate [1]. Dissolution of poorly soluble drug 
meets a great confrontation in the assaying of new chemical 
existence also in preparation, design and sophisticating [2]. There 
are many of systematics exploited to enhance the drug dissolution of 
poorly soluble in water and more to raise its bioavailability. The 
micellar solubilisation, micronization, solid dispersion, chemical 
modification, complexation, pH adjustment, co-solvency, 
hydrotropy, etc. are conventional approaches to the dissolution of 
the drug and bioavailability enhancement [3]. The drug solubility in 
an aqueous media and drug permeability through hydrophobic 
membranes are important parameters in improving bioavailability. 
In fact, the drug molecules should be present in a solubilized form in 
order to absorb by the cell membrane and arrive the site of drug 
action [4]. The practically insoluble compounds in aqueous media 
represent more than 40% of new chemical existence in the 
pharmaceutical industry and make a coalition to slow absorption of 
drug that cause insufficient and changeable bioavailability and 
toxicity of the gastrointestinal tract [5]. Carvedilol is An 
antihypertensive that has non selective β-blocking, α-adrenergic 
blocking activity and antioxidant properties, is practically water 
insoluble [6]. Nan emulsions defined as a drug delivery system 
composing of emulsified oil and the aqueous phase with an average 
globule diameters rating about 50 to 1000 nm. Normally, the mean 
globule size is about 100 to 500 nm and present mainly as water-in-
oil (w/o) and oil-in-water (o/w) design, where the essence of the 
globule is either water or lipid, respectively. Srilatha et al. Formulate 
glipizide nano emulsion. The results of pharmacodynamic assay 
found that the selected preparation (F9) decreased blood glucose 
level up to 12 h [7]. Preeti K Suresh and Sudhanshu Sharma, develop 
cinnarizine self-nano emulsifying drug delivery system (SNEDDS). 
They found that SNEDDS with a surfactant: co-surfactant (Smix) 
ratio (2:1) and (Smix)-oil ratio (6:1) has the highest release of the 
drug [8]. Thus, the aim of this investigation is a formulation and 
characterization of carvedilol nano emulsion employing orally for 
enhancement of carvedilol solubility result consequently in an 
increased bioavailability. 
MATERIALS AND METHODS  
Materials 
Carvedilol supplied by Wadi Al-Rafidian factory for pharmaceutical 
products, Baghdad, Iraq. Ginger oil, cyperus oil and black seed oil from 
AI-Emad for plant oil product, Iraq. Anise oil and peppermint oil from 
BAR-SUR-loup Grasse A. M Franc. Garlic oil from ATI laboratory, 
Holland. Tween 80 from SD fine Chemlimited (SDFCL) Mumbai, India. 
Propylene glycol from AOBA Chemie India. Tween 20, methanol and 
ethanol from grin land chemical comp, United Kingdom. 
Method 
Components screening by solubility determination 
The carvedilol solubility was determined in various soils which are 
ginger oil, black seed oil, anise oil, peppermint oil, cyperus oil and 
garlic oil, surfactants (tween 80 and tween 20) and co-surfactants 
(methanol, ethanol and propylene glycol). The excess quantity of the 
carvedilol was added to 2 ml of various oils, surfactants and co-
surfactant that contained in the small plain tube. The plain tube was 
tightly closed and was continuously shaked on an isothermal shaker 
water bath for 72 h at 37+/-0.05 °Cand then specimens were 
centrifuged 15 min at 3000 rpm. The afloat was filtered through a 
microfilter paper (0.45 μm) and after adequate methanol dilution, 
solubility was measured through a UV spectrophotometer at the λmax 
285 nm [9]. The measurements were performed in triplicate. 
Construction of pseudo ternary phase diagrams 
The components of the pseudo ternary phase plot, including of oil, 
Smix and aqueous phase and it is developed by employing the aqueous 
phase titration technique [10]. Surfactant and co-surfactant that meld 
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in various weight ratios (1:1, 2:1, 3:1, 4:1) was chosen on the basis of 
increment the concentration of surfactant at a constant concentration 
of co-surfactant. Oil and a particular Smix ratio were blended 
appropriately in various weight ratios for each phase graphing, so that 
maximum ratio were obtained.  
In order to know the borderline of phases specifically con fig. in each 
phase graphing, slow titration of each weight ratio of Smix and oil was 
achieved with distilled water and visual searches were made for 
evaluating transparency where the distilled water was added drop by 
drop until the nano emulsified blend is clear to the eyes, after that 
further addition of distilled water was stopped and various o/w nano 
emulsion formed. The pseudo ternary phase diagram was constructed 
by using triplot V4 software (4.1.2. Version). The plotted area of nano 
emulsion represented by the shaded area and the wider region 
indicated better nano emulsifying activity. No heating was conducted 
during the preparation. 
Screening of carvedilol nano emulsion formulations on the 
basis of thermodynamic stability studies [11] 
The thermodynamic stability assays were achieved depending on 
the following tests.  
Centrifugation assay 
The chosen preparations were centrifuged for 30 min at the 5000 
rpm and noticed the phase separation, creaming and cracking. The 
chose formulations should have the maximum stability that is no 
phase separation, creaming and cracking can be seen. The succeeded 
formulations exposed to other thermodynamic stability tests. The 
measurements were performed in triplicate. 
Heating-cooling test 
It is utilized to show the racking effect of heating and cooling on the 
nanoemulsions stability where the preparations should kept at 45 oC 
and at 0 oC temperature for not less than 48 h for each temperature 
test. The measurements were performed in triplicate. 
Freezing–thawing test 
This test was achieved for accelerated stability assaying of 
nanoemulsion formulations. The formulations were subjected at two 
different temperatures, which are (-21oC and 21oC) for each 
temperature test not less than 24 h. The measurements were 
performed in triplicate. 
Characterization of the prepared carvedilol nanoemulsion 
Globule size assay 
The specimens of nanoemulsion were put in a 5 ml cell of ABT-9000 
nanolaser particle size analyzer after sonication at the 37 oC for 30 
min, globule size distribution plots were received and the mean 
globule size can be obtained. The measurements were performed in 
triplicate. 
Poly dispersity index (PDI) assay 
It measures the uniformity of globules size in nanoemulsion and can 
be obtained by ABT-9000 nanolaser particle size analyzer. The 
measurements were performed in triplicate. The higher the poly 
dispersity value refers to the lower uniformity of globules size of 
nanoemulsion [12]. 
Zeta potential (ZP) assay 
Zeta potential for nanoemulsion was determined by brook heaven 
instrument USA zeta sizer. Samples were placed in clean disposable 
zeta cells then recording the results. Before putting the new sample, 
cuvettes were rinsed with the methanol and the sample to be 
measured before each test [13]. Zeta potential values were 
determined in triplicate for all nanoemulsions. 
Determination of pH 
The pH is one of the major parameters in nanoemulsion. 
Observation the pH value is consequential for determining the 
stability of the nanoemulsion due to the pH alteration mean 
occurrence of chemical reactions that can impair the quality of 
the final product. The digital pH meter utilizes to determine the 
pH of the formulations. Results were being taken in triplicate 
[14]. 
Electrical conductivity assay 
The electrical conductivity definition is highly important to 
determine the type of the continuous phase and to find out the 
phenomena of phase inversion. Conductivity measurements were 
executed by a conductivity meter [15]. The measurements were 
performed in triplicate. 
Percent of light transmittance assay 
The nano emulsion percent transmittance was measured by UV-
Visible spectrophotometer keeping distilled water as blank at 600 
nm [16]. The measurements were performed in triplicate. 
Drug content estimation [17] 
The drug content was determined using a UV-visible 
spectrophotometer. The formula was diluted to desirable 
concentration through employing methanol as solvent. The 
measurements were performed in triplicate. The absorbance was 
determined at 285 nm and the drug content was obtained by the 
following equation:  
Drug content = (Analyzed content/Theoretical content) x 100  (Eq 1) 
Viscosity measurement 
By NDJ-55 digital Viscometer using a spindle no. 1 at 25 °C, the 
viscosity of the formulations was measured as it is without dilution. 
The measurements were performed in triplicate. 
In vitro release study 
By USP dissolving apparatus II (Copley dissolution tester DIS 8000, UK) 
using the dialysis bag technique, the in vitro carvedilol release from the 
optimized nanoemulsions was performed. The dissolving medium for in 
vitro release analysis was phosphate buffer pH 6.8 with 1% tween 80. 
The quantity of carvedilol in nanoemulsion and the pure carvedilol 
solution was 1.5 mg of carvedilol and put in the dialysis bag, and then the 
dialysis bag submerges in 500 ml of dissolution medium and set at 
37±0.5 °C and rotating velocity is at 50 rpm. An aliquot of 5 ml were 
siphoned at regular intervals of time (10, 20, 30, 40, 50, 60, 75, 90, 120, 
150, 180 min) and filtered using microfilter paper with pore size is 0.45 
µm. An equal volume of the dissolving medium was added to obtain 
constant total volume. The drug content of the specimens was assayed 
by a UV-visible spectrophotometer at 285 nm wavelength. All analogies 
were done in triplicate [18]. 
Kinetic analysis of drug release [19] 
The in vitro release data were corresponded into differential 
equations and release kinetic models to excuse the release kinetics 
of carvedilol from nanoemulsions. The kinetic models exploited 
were zero-order (cumulative % drug dissolved against time), first-
order (log cumulative % of drug undissolved against time), Higuchi 
(cumulative % amount of drug dissolved against the square root of 
time) and Korsemeyer-Peppas (log cumulative % of drug dissolved 
against log time) models. 
Drug-excipient compatibility study 
Fourier transformed infrared spectroscopy (FTIR) 
The study of interactions between drug and excipients achieved by 
FTIR Spectroscopy. IR spectrum of pure drug and the physical 
mixture at a ratio (1:1) of carvedilol with all components of 
nanoemulsion was carried out where the range was selected from 
400 cm-1 to 4000 cm-1 [20]. 
Atomic force microscopy (AFM) study 
The shape and size of carvedilol nanoemulsion were detected by 
AFM angstrom advanced inc. AA3000 USA. AFM analysis was 
achieved by putting drops of the nanoemulsion onto a glass slide and 
then measure [21]. 
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Statistical analysis 
Agreeing to the analysis of variance (ANOVA) assay. The results of 
the investigation were given as an average of triplicate specimens 
were studied at level (P<0.05) [22]. 
RESULTS AND DISCUSSION 
Components screening by solubility determination 
One of the important factors to formulate a stable nanoemulsion system 
is choosing components of nanoemulsion which are oil, surface active 
agent and co-surfactant. The more imperative for the nanoemulsion 
formulation is a higher solubility of carvedilol in the oily phase rather 
than solubilization of drug in the surfactant or co-surfactant due to the 
gastrointestinal tract dilution of nanoemulsion will yield to a lower 
solvability of surfactant or co-surfactant that leading to risk of drug 
precipitation [23]. The outcomes of solubility of carvedilol in the 
components of nanoemulsion indicate that the solubility in various oils 
was in the following descending order; peppermint oil>anise oil>ginger 
oil>black seed oil>garlic oil>cyperus oil as shown in table 1. However, 
carvedilol has a higher solubility in peppermint oil, thus peppermint oil 
was chosen as oil phase for the formulation of nanoemulsions. The 
solubility of carvedilol in surfactants was in the following descending 
order; tween 80>tween 20 as presented in table 1. The solubility of 
carvedilol in co-surfactants was in the following descending order 
methanol>ethanol>propylene glycol as shown in table 1thus, co-
surfactant ethanol was selected for the study as it showed high drug 
solubility due to shorter chain length and less viscosity than propylene 
glycol and less toxicity than methanol [24]. Thus, depending on solubility 
studies the nanoemulsion components which are the peppermint oil as 
oil, tween80 as a surfactant, and ethanol as co-surfactant was selected 
for the preparation of the nomination system. 
 
Table 1: Solubility studies 
S. No. Oils, surfactants and co-
surfactants 
Solubility (mg/ml) 
1 Ginger oil 15.841 
2 Black seed oil 3.662 
3 Anise oil 17.959 
4 Peppermint oil 31.937 
5 Cyperus oil 2.497 
6 Garlic oil 3.026 
7 Tween 20 11.816 
8 Tween 80 16.492 
9 Propylene glycol 9.148 
10 Methanol 17.175 
11 Ethanol 12.436 
 
Construction of pseudo-ternary phase diagrams 
Pseudoternary phase plots were made by variable Smix ratios as 1:1, 
2:1, 3:1, and 4:1 as shown in figs. 1–4. The shaded regions of phase 
plots display the areas of nanoemulsion, whereas the region that is 
non-shaded displays the area of emulsion. 
 
Fig. 1: Pseudoternary phase diagram of peppermint oil, tween 
80, ethanol and distilled water (Smix 1:1) 
 
Fig. 2: Pseudoternary phase diagram of peppermint oil, tween 
80, ethanol and distilled water (Smix 2:1) 
 
 
Fig. 3: Pseudoternary phase diagram of peppermint oil, tween 
80, ethanol and distilled water (Smix 3:1) 
 
 
Fig. 4: Pseudoternary phase diagram of peppermint oil, tween 
80, ethanol and distilled water (Smix 4:1) 
 
Screening of carvedilol nanoemulsion formulations on the basis 
of thermodynamic stability studies [25] 
The outcomes of the thermodynamic study, which is centrifugation, 
heating-cooling cycles and freeze-thaw cycles. The outcomes 
indicate that all the preparations had an excellent physical stability 
as shown infig.5. Depend on thermodynamic stability results and 
criteria exploited for the choice of various formulations from the 
phase diagrams, we select the eight formulas which are F4 (NE1), F6 
(NE2), F10 (NE3), F12 (NE4), F16 (NE5), F18 (NE6), F22 (NE7), F24 
(NE8) for characterization of globule size, PDI, zeta potential, pH, 
electrical conductivity, percent of light transmittance, viscosity and 
in vitro release study. 
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Photographic picture (A) 
 
Photographic picture (B) 
 
Photographic picture (C) 
Fig. 5: Inferential photographic pictures (A), (B) and (C) where 
it represented the carvedilol nanoemulsion formulations of F1-
F8, F9-F16 and F17-F24 respectively 
 
Characterization of the prepared carvedilol nanoemulsion  
Globulesize assay 
The results globule size range was NE1 (50-70.6 nm); NE2 (25-31.5); 
NE3 (11.1-158 nm); NE4 (5-125 nm); NE5 (9.97-199 nm); NE6 (5-140 
nm); NE7 (56.1-70.6) and NE8 (111-140) that have tween 80: ethanol 
(%w/w) concentrations 40, 50, 30, 40, 40, 50, 50, 60 respectively. All 
the preparations had droplets in the nano scale [26]. Analysis of 
variance indicated significant correlativity between globule size values 
and independent variables (%w/w of Smix) where (p<0.05). 
Polydispersity index (PDI) assay 
PDI was from (0.007 to 0.135). The results of PDI indicated that 
nanoemulsion formulations had a high homogeneous and constrict 
size distribution. 
Zeta potential assay 
Zeta potential is an index of the nanoparticle dispersion stability. 
The results of the mean zeta potential scale (-10.45 to-22.56 mV) 
which indicate the stability of nanoemulsions. There should be a 
higher electrical charge on the NEs surface in order to preclude 
aggregation of the nanoemulsions in the solutions due to the strong 
resistance violence among particle. Zeta potential absolute values 
according to thumb rule are: the range-5 mV to+5 mV show fast 
aggregation, about 20 mV supply only short term stability, above 30 
mV offers good stability and above 60 mV excellent stability[27]. The 
thumb rule can apply for perfect electric stabilization and stabilizers 
of small molecular weight, but not for large or great molecular 
weight surfactants such as tween 80 which is nonionic stabilizers 
that has a steric stability for conserving the NE stability [28]. 
Determination of pH 
The carvedilol nanoemulsion formulations had suitable noticed pH value 
in the range of (7.04-7.25) that is better for oral administration  
Electrical conductivity assay 
The carvedilol nanoemulsions formulations had the average 
conductivity in the range of (0.16-0.30 ms/cm) that is shown o/w 
structure of nanoemulsions [29]. 
Percent of light transmittance assay 
The percent transmittance of the all preparations was computed at 
(600 nm) where the blank was distilled water. The percent 
transmittance of the optimized preparations was found in a range 
from (96.161 % to 98.174%). The results of percent transmittance 
illustrate that all the formulations were closely transparent [30]. 
Drug content estimation 
The outcome of drug content was in a range of (90.972-99.445%). 
The drug content deviated for up to 8.473 % between formulations 
NE1 to NE8. 
Viscosity measurement 
It was mostly noticed a very low viscosity of the carvedilol 
nanoemulsion preparations where the range was (41.937-241.603 
mPa. sec). This was expected, due to one of the characteristic 
parameters of nanoemulsion preparations is of lower viscosity and 
this ensures comfortable handling, packing and smoothen 
formulations administration of preparations. Agreeing to analysis of 
variance, there is a significant difference (P<0.05) between 
carvedilol nanoemulsions. 
In vitro release studies 
Drug release analysis was done for the pure drug and carvedilol 
nanoemulsions by employing the dialysis bag technique. Outcomes 
of carvedilol release from pure drug and carvedilol nanoemulsions 
that hold peppermint oil, tween 80 (surfactant) and ethanol (co-
surfactant) which are{NE1,NE2 have oil: Smix (1:1): distilled water 
(10:40:50) and (10:50:40) ratio respectively}, {NE3,NE4 have oil: 
Smix (2:1): distilled water (10:30:60) and (10:40:50) ratio 
respectively}, {NE5,NE6 have oil: Smix (3:1): distilled water 
(10:40:50) and (10:50:40) ratio respectively} and {NE7,NE8 have 
oil: Smix (4:1): distilled water (10:50:40) and (10:60:30) ratio 
respectively} in phosphate buffer pH (6.8) with tween 80 1% (w/w) 
is presented in fig. 6. The profile of carvedilol release was 
significantly higher (P<0.05) in dissolution rate for the 
carvedilolNE3 with oil: Smix (2:1): distilled water (10:30:60) ratio 
while carvedilol release profile was significantly lower (P<0.05) in 
dissolution rate of the pure drug. The comparability profile of the 
drug release of pure drug and nanoemulsions NE1, NE2, NE3, NE4, 
NE5, NE6, NE7andNE8 reveal that the profile of drug release of 
nanoemulsions confirms the order: NE3>NE1>NE4> NE2>NE5> 
NE6>NE7>NE8>pure drug and the profile of drug release of 
nanoemulsions with Smix (1:1), Smix (2:1), Smix (3:1), Smix (4:1) 
confirm the order: NE1>NE2, NE3>NE4, NE5>NE6 and NE7>NE8 
respectively. The release profile of all nanoemulsions in phosphate 
buffer pH (6.8) reflects the effect of surfactant concentration on the 
carvedilol release in each Smix ratio at a constant concentration of 
oil. As tween 80 concentration increase, the carvedilol release 
decrease due to that carvedilol molecules encounter retarding effect 
from tween 80 molecules also increase diffusional pathway for 
carvedilol molecules to reach dissolution medium after passing from 
dialysis bag and therefore we found that the profile of drug release 
of the nanoemulsions with Smix (1:1), Smix (2:1), Smix (3:1) and Smix 
(4:1) follow the order: NE1>NE2, NE3>NE4, NE5>NE6 and NE7>NE8 
respectively. It was found that carvedilol release was more for the NE3 
with oil: Smix (2:1): Distilled water (10:30:60) ratio due to the least 
tween 80 concentration and this gives the less retarding effect from 
tween 80 molecules and shorter diffusional pathways for carvedilol 
molecules to reach dissolution medium. Also, it is observed that 
carvedilol release was lower from nanoemulsions NE8 compared to 
other nanoemulsion formulations have oil: Smix (4:1): distilled water 
(10:60:30) ratio because higher tween 80 concentrations and this 
gives more retarding effect from tween 80 molecules and longer 
diffusional pathways for carvedilol molecules to reach dissolution 
medium. It was observed that the pure drug gives a lower dissolution 
rate of carvedilol profile in comparison to all nanoemulsion 
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formulations because that the reduction of drug particle size in 
nanoemulsion caused an increase in the surface area and permits a 
higher interaction with the solvent that result in an increase in 
dissolution rate [31]. 
 
 
Fig. 6: Dissolution comparison of pure drug and nanoemulsion formulations where (A)Release profile of pure drug, NE1 and NE2 
(B)Release profile of pure drug, NE3 and NE4 (C) Release profile of pure drug, NE5 and NE6 (D)Release profile of pure drug, NE7 and NE8 
 
Kinetic analysis of drug release 
The kinetic data of various nanoemulsion formulations were 
summarized in tables2. The data analysis illustrates that excellent 
regression coefficient (R2) was received for Higuchi's equation, 
which suggested that the released of a drug in the idealistic matrix in 
all preparations was Higuchi’s diffusion. The ‘n’ values (release 
exponent), of all nanoemulsion formulations, were significantly 
lower (P<0.05) than 0.45 indicating that the release of carvedilol 
from formulations following fickian transport i. e diffusion. 
 
Table 2: The correlation coefficient (R2) and release exponent (n) of different kinetic models of prepared nanoemulsions (NE1-NE8) and 
the pure drug released in phosphate buffer pH (6.8)+1 % (w/w) tween 80 solution 
Korsemeyer-peppas model Higuchi model First Order model Zero Order model Formulation Code 
n R2 R2 R2 R2 
0.1797 0.8864 0.9587 0.9304 0.9432 NE1 
0.1825 0.9947 0.9963 0.9925 0.9553 NE2 
0.1173 0.8811 0.9259 0.8912 0.8758 NE3 
0.3212 0.8253 0.9695 0.7611 0.9352 NE4 
0.1005 0.934 0.9653 0.9564 0.9343 NE5 
0.1593 0.9663 0.9816 0.9808 0.9622 NE6 
0.2594 0.9833 0.9952 0.9944 0.9844 NE7 
0.3295 0.969 0.9698 0.9683 0.9616 NE8 
0.2457 0.9906 0.9939 0.9931 0.9918 Pure drug 
Where R=regression coefficient, n= diffusion exponent 
 
Selection of the optimized formula 
From study of the globule size analysis, PDI, zeta potential 
measurements, pH, electrical conductivity, percent of light 
transmittance, drug content, viscosity and in vitro release studies 
behavior of the nanoemulsion formulations (NE1-NE8) it was 
found that NE3 is selected formula that characterized by a low 
particle size range (11.1-158 nm) as shown in fig. 7, low PDI 
(0.030), higher zeta potential (-22.56 mV), good pH value (7.12), 
efficient electrical conductivity (0.30 ms/cm), classy percent of 
light transmittance (97.274), higher % drug content (99.445), 
acceptable low viscosity (0.00105 Pa. s) and higher dissolution 
rate. The selected formula (carvedilol NE3) subject for further 
investigations of drug-excipient compatibility and atomic force 
microscopy (AFM) study. 
Drug-excipient compatibility studies 
Fourier transformed infrared spectroscopy (FTIR) 
The result of the FTIR spectrum of pure carvedilol showed the peaks as 
described in fig.8 was 3342.75 (Aliphatic Secondary amine, NH stretch), 
1629.9 (Secondary amine NH bend), 1174.69 (Secondary amine, CN 
stretch), 1346.36(Aromatic Secondary amine, CN stretch), 3450 
(Aromatic Secondary amine, NH stretch), 3203.87(Hydroxy group, H-
bonded OH stretch), 1097.53 (Secondary alcohol, C-O stretch), 1303.92 
(Primary or secondary, OH in-plane bend), 617.24(Alcohol, OH out-of-
plane bend), 2820 (Methoxy (CH3-O-), C-H stretch), 1253.77 (Aromatic 
ethers, Aryl-O stretch), 2922.25 (Methylene C-H asymmetric stretch), 
2847.03(Methylene C-H symmetric stretch),1448.66 (Methylene C-H 
bend),1606.76, 1587.47 and1502.6 (Aromatic ring stretch(C=C)), 3090 
(Aromatic C-H stretch), 1213.27 (Aromatic C-H in-plane bend), 
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748.41(Aromatic C-H out-of-plane bend, these peaks were 
corresponding with the described one which suggests the drug purity. 
Also the spectrum of physical mixture (1:1) of carvedilol with all 
nanoemulsion components which are tween 80, ethanol and 
peppermint oilas shown in fig. 9were studied by FTIR spectroscopy 
using KBR disc. The results show that the characteristic peaks of 
carvedilol not affected and prominently observed in all described IR 
spectra, this indicated that there is no incompatibility between the 




Fig. 7: The particle size distribution for NE3 
 
 
Fig. 8: FTIR spectra of pure carvedilol 
 
 
Fig. 9: FTIR spectra of physical mixture (1:1) of carvedilol, tween 80, ethanol and peppermint oil 
Drais et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 12, 209-216 
215 
 
Atomic force microscopy study [32] 
The AFM study that described in fig. 10, confirm that the system in 
nanoscale and has high stability against aggregations of particles 
within carvedilol NE. 
 
Fig. 10: AFM image of carvedilol nanoemulsion (NE3) where 
scanning area is 2 µm * 2 µm 
 
CONCLUSION 
1. An aqueous phase titration method which is low energy 
emulsification methods employ low energy that consolidate the 
nanoemulsions manufacture by decrease the cost and increase 
stability. 
2. In-vitro dissolution study provided a significant increase in the 
solubility of carvedilol for NE3 compared to pure drug and other 
nanoemulsion formulations thus; NE3 can be regarded as 
commercially feasible alternative to formulate a carvedilol 
preparation to be employed orally. 
3. Nanoemulsion NE3 which is a fat base formulation has accepted to 
meliorate the bioavailability potential of the hydrophobic drugs by 
increment their dissolution and permeation therefore the NE3 can 
be used for oral delivery of the biopharmaceutics classification 
system (BCS) class II and IV drugs. 
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